transcranial magnetic resonance guided focused ultrasound BBB disruption for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Aug 2020: Trial registered, NCT04526262

The trials

NCT04526262: Assessment of Initial Efficacy and Safety of High Intensity Focused Ultrasound 'ExAblate 4000 Type 2' for Blood Brain Barrier Disruption in Patients With Alzheimer's Disease

State
State not given
Phase
No phase
People
6 planned
Started
10 Apr 2020
Primary completion
Dec 2020
Arms
BBB disruption
Results
None posted
  1. 10 Apr 2020: Trial started
  2. 25 Aug 2020: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Device.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.